fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

CHMP adopts a positive opinion for change to the marketing authorisation for zoonotic influenza vaccine Seqirus (Aflunov) – CSL

Written by | 20 Jun 2025

The Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending a change to the marketing authorisation for Zoonotic Influenza Vaccine Seqirus. The marketing authorisation… read more.

Study reveals gaps in flu treatment for high-risk adults

Written by | 4 May 2025

A multi-state study reveals that many high-risk adults diagnosed with influenza (flu) in emergency departments and urgent care centers are not receiving timely antiviral treatment. Researchers found that… read more.

Blood test can predict how long vaccine immunity will last, Stanford Medicine-led study shows

Written by | 3 Jan 2025

When children receive their second measles-mumps-rubella vaccine, around the time they start kindergarten, they gain protection against all three viruses for all or most of their lives. Yet… read more.

Study shows drop in use of antiviral medications in young children with influenza

Written by | 21 Dec 2024

Despite national medical guidelines supporting the use of antiviral medications in young children diagnosed with influenza, a recent study reports an underuse of the treatment. “Antiviral Use Among… read more.

CHMP positive for Flucelvax vaccine to prevent influenza

Written by | 24 Oct 2024

The Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a marketing authorisation for the medicinal product Flucelvax, intended for the prevention of influenza… read more.

AstraZeneca Set to Reveal New Data on Immunotherapies and Vaccines at Upcoming IDWeek 2024

Written by | 17 Oct 2024

AstraZeneca will share new data across its Vaccines & Immune Therapies portfolio at the 13th annual IDWeek in Los Angeles, California, from 16-19 October 2024. The Company will highlight… read more.

FluMist nasal spray approved for self-administration in the US – AstraZeneca

Written by | 26 Sep 2024

FluMist has been approved in the US as the only self-administered influenza vaccine. FluMist, a needle-free nasal spray, was approved to be self-administered by adults up to 49… read more.

Positive phase III results show Xofluza (baloxavir marboxil) significantly reduces the transmission of influenza viruses – Genentech/Roche

Written by | 24 Sep 2024

Genentech, a member of the Roche Group , announced t positive topline results of the Phase III CENTERSTONE study of Xofluza (baloxavir marboxil), an antiviral, showing a reduction in… read more.

Study shows promise for a universal influenza vaccine

Written by | 21 Jul 2024

New research led by Oregon Health & Science University reveals a promising approach to developing a universal influenza vaccine — a so-called “one and done” vaccine that confers… read more.

Molecule produced in gut may protect against flu

Written by | 8 Jul 2024

A naturally occurring molecule could help to prevent – and even treat – influenza, according to a new study published in the journal Gut Microbes. The molecule, indole-3-propionic… read more.

Flu vaccines to target three virus strains this autumn

Written by | 7 Jul 2024

Vaccine manufacturers have been tasked with producing vaccines that protect against three influenza viruses, as Europe gears up for another flu season. Companies are actively producing millions of… read more.

Simple test for flu could improve diagnosis and surveillance

Written by | 25 Jun 2024

Fewer than one percent of people who get the flu every year get tested, in part because most tests require trained personnel and expensive equipment. Now researchers have… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.